South-East Asia (WHO region) vs Syria: Treatment success rate: HIV-positive TB cases
South-East Asia (WHO region)
80
in 2023
Syria
100
in 2023
South-East Asia (WHO region) rank
4th
Syria rank
1st
Treatment success rate: HIV-positive TB cases over time
- South-East Asia (WHO region)
- Syria
How they compare
Syria currently reports 100 against 80 in South-East Asia (WHO region), a difference of 20.
That makes Syria's figure about 1.2 times South-East Asia (WHO region)'s.
The two have swapped places 6 times across 10 shared years of data; in 2010 it was Syria ahead.
South-East Asia (WHO region) ranks 4th and Syria ranks 1st of 11 groups.
Across the 2 decades both report, South-East Asia (WHO region) averaged higher in 1 and Syria in 1.
Head to head by decade
| Decade | South-East Asia (WHO region) | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.71 | 64.43 | 9.29 | South-East Asia (WHO region) |
| 2020s | 76.67 | 89 | 12.33 | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: hiv-positive tb cases, South-East Asia (WHO region) or Syria?
- Syria, at 100 against 80 in South-East Asia (WHO region) as of 2023.
- What is the difference in treatment success rate: hiv-positive tb cases between South-East Asia (WHO region) and Syria?
- 20, with Syria ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Syria?
- 10 years are reported by both, from 2010 to 2023.
- How do South-East Asia (WHO region) and Syria rank globally for treatment success rate: hiv-positive tb cases?
- South-East Asia (WHO region) ranks 4th and Syria ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: HIV-positive TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.